Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics
WATERTOWN, Mass, September 8, 2020 – C4 Therapeutics, Inc. (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs
September 8, 2020
News
Menu
C4 Therapeutics Announces the Additions of William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer
WATERTOWN, Mass, July 15, 2020 – C4 Therapeutics, Inc. (C4T), a biotechnology company pioneering a new class of small-molecule drugs
July 15, 2020
C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-concept and to Advance Proprietary Platform
–Multiple oncology-focused programs poised to enter clinical trials in 2021 and 2022– WATERTOWN, Mass, June 16, 2020 – C4 Therapeutics, Inc. (C4T), a
June 16, 2020
